tiprankstipranks
Trending News
More News >
China SXT Pharmaceuticals Inc (SXTC)
NASDAQ:SXTC
US Market
Advertisement

China SXT Pharmaceuticals (SXTC) Income Statement

Compare
273 Followers

China SXT Pharmaceuticals Income Statement

Last quarter (Q4 2024), China SXT Pharmaceuticals's total revenue was $494.46K, a decrease of -35.23% from the same quarter last year. In Q4, China SXT Pharmaceuticals's net income was $3.30M. See China SXT Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 1.74M$ 1.93M$ 1.97M$ 2.60M$ 4.78M
Gross Profit
$ 367.43K$ 553.97K$ 426.27K$ 1.25M$ 2.84M
Operating Expenses
$ 3.05M$ 3.07M$ 6.03M$ 6.44M$ 5.04M
Depreciation and Amortization
$ 82.30K$ 203.25K$ 250.16K$ 320.01K$ 345.41K
EBITDA
$ -2.57M$ -2.35M$ -5.21M$ -5.05M$ -1.85M
Operating Income
$ -2.68M$ -2.52M$ -5.61M$ -5.19M$ -2.20M
Other Income/Expenses
$ -623.17K$ -583.32K$ -327.26K$ -218.28K$ -743.79K
Pretax Income
$ -3.30M$ -3.10M$ -5.93M$ -5.41M$ -2.94M
Net Income
$ -3.30M$ -3.10M$ -5.93M$ -5.74M$ -2.75M
Per Share Metrics
Basic EPS
$ -8.18$ -3.57$ -22.23$ -137.92$ -95.48
Diluted EPS
$ -8.18$ -3.57$ -22.23$ -137.92$ -95.48
Weighted Average Shares Outstanding
403.92K 867.42K 266.97K 41.59K 28.78K
Weighted Average Shares Outstanding (Diluted)
403.92K 867.42K 266.97K 41.59K 28.78K
Currency in USD

China SXT Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis